Treatment of hepatitis C in two paediatric patients using sofosbuvir during haematopoietic stem cell transplantation.
We report the first two pediatric cases of sofosbuvir treatment during high-intensity myeloablative conditioning and engraftment phases of hematopoietic stem cell transplantation. These reports highlight the safety of sofosbuvir during all phases of transplantation and the lack of interaction between sofosbuvir and alkylating or immunosuppressive agents.